1. Catalog
  2. Perioperative Medication Management Controversies ...
Perioperative Medication Management Controversies - On Demand 2025
Rethink perioperative prescribing with a clinician-led deep dive into today’s most debated decisions. In this on‑demand session, faculty analyze emerging evidence and describe practical timing for holding or continuing GLP‑1 RAs, SGLT2 inhibitors, ACEi/ARBs, biologics, glucocorticoids, and buprenorphine; examine risks such as euglycemic DKA; and evaluate guideline conflicts—so you finish ready to design safer, clearer plans.
Create Account
Availability
On-Demand
Expires on May 06, 2028
Credit Offered
0.75 CME Credit
0.75 ABIM-MOC Point
0.75 Participation Credit
  • Overview
  • Faculty
  • Accreditation
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. Describe the risk of euglycemic diabetic ketoacidosis with the use of SGLT2 inhibitors and the rationale for stopping them before surgery.
  2. Evaluate the recommendations for the perioperative management of GLP-1 receptor agonists.
  3. Analyze recent evidence for stopping (or continuing) ACE inhibitors and ARBs in the perioperative period.
  4. Examine the evidence for managing commonly used medications for rheumatologic disease in the perioperative period including TNF alpha inhibitors, JAK inhibitors, and glucocorticoids ("stress-dose" steroids).
  5. Evaluate the recommendations for the perioperative management of buprenorphine.
Faculty
  • Paul Grant
  • Alana E. Sigmund, MD, FHM
    • Dr. Sigmund reports owning stock in CVS, Briston Myers Squibb, Walgreen's, and Pfizer.

Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.

 

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75  MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IOS App Download Powered By